-
Reversible myocardial dysfunction may be much more common in critical illness than has been generally appreciated.
-
Recent reports from Paris that scores of patients developed aplastic anemia after receiving eprex, the oxygen therapeutic drug known generically as erythropoietin (EPO), have some stateside researchers puzzled.
-
Despite measures taken following the resurgence of TB cases in the late 1980s and early 1990s, many health care workers still poorly understand respiratory isolation procedures, says Kevin P. Fennelly, MD, MPH, researcher at the Center for Emerging Pathogens of the New Jersey Medical School in Newark.
-
As hospitals struggle to comply with aspects of the Emergency Medical Treatment and Labor Act (EMTALA), one thorny issue is whether patients can be transferred from an ICU of one hospital to the emergency department of another hospital, based on an accepting physicians request.
-
-
As IRBs prepare for their first accreditation surveys or consider the pros and cons of applying for accreditation, some who have gone through it say that preparation can be its own reward.
-
When IRB members and investigators discuss potential risks and benefits, they typically break down the benefits into two categories: individual and societal. But there is a third category that should be considered for some research projects: community.
-
U.S. human research funding has a global reach. Each year, millions of dollars, both public and private, go to institutions conducting human subjects research outside this country.
-
-
One of the keys to successful surveys is to spend time, sometimes as much as a year, preparing for the process. Here are some tips from IRB officials who have either been through the process or who have begun it, as well as from other experts, on how to best prepare for an accreditation survey.
